RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Karolinska Development Stock

Karolinska Development Net Income 2024

Karolinska Development Net Income

-27.26 M SEK

Ticker

KDEV.ST

ISIN

SE0002190926

WKN

A0M84G

In 2024, Karolinska Development's profit amounted to -27.26 M SEK, a -606.17% increase from the 5.39 M SEK profit recorded in the previous year.

The Karolinska Development Net Income history

YEARNET INCOME (undefined SEK)
2026e-16.36
2025e-27.26
2024e-27.26
20235.39
2022-88.12
2021170.82
2020-207.49
2019302.98
201830.51
2017179.6
2016-216.83
2015-1,054.67
2014-371.49
2013-157.32
2012-212.85
2011-354.15
2010-325.62
2009-2.81
2008-57.71
2007-6.19
2006-0.48

Karolinska Development Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Karolinska Development, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Karolinska Development from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Karolinska Development’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Karolinska Development. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Karolinska Development’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Karolinska Development’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Karolinska Development’s growth potential.

Karolinska Development Revenue, EBIT and net profit per share

DateKarolinska Development RevenueKarolinska Development EBITKarolinska Development Net Income
2026e2.04 M undefined-30.6 M undefined-16.36 M undefined
2025e2.04 M undefined-29.58 M undefined-27.26 M undefined
2024e2.04 M undefined-23.46 M undefined-27.26 M undefined
20232.01 M undefined-18.69 M undefined5.39 M undefined
20222.3 M undefined-11.34 M undefined-88.12 M undefined
20212.17 M undefined-62.5 M undefined170.82 M undefined
20202.65 M undefined12.95 M undefined-207.49 M undefined
20193.38 M undefined-67.2 M undefined302.98 M undefined
20183.07 M undefined15.54 M undefined30.51 M undefined
20172.46 M undefined-31.56 M undefined179.6 M undefined
20165.36 M undefined-27.51 M undefined-216.83 M undefined
20152.94 M undefined-43.8 M undefined-1.05 B undefined
20145.03 M undefined-63.56 M undefined-371.49 M undefined
20134.95 M undefined-58.75 M undefined-157.32 M undefined
20129.94 M undefined-167.02 M undefined-212.85 M undefined
201110.48 M undefined-156.88 M undefined-354.15 M undefined
201013.9 M undefined-119.47 M undefined-325.62 M undefined
200930.32 M undefined-43.57 M undefined-2.81 M undefined
200823.23 M undefined-41.02 M undefined-57.71 M undefined
200790,000 undefined-6.15 M undefined-6.19 M undefined
20060 undefined-490,000 undefined-480,000 undefined

Karolinska Development stock margins

The Karolinska Development margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Karolinska Development. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Karolinska Development.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Karolinska Development's sales revenue. A higher gross margin percentage indicates that the Karolinska Development retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Karolinska Development's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Karolinska Development's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Karolinska Development's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Karolinska Development. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Karolinska Development's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Karolinska Development Margin History

Karolinska Development Gross marginKarolinska Development Profit marginKarolinska Development EBIT marginKarolinska Development Profit margin
2026e-350.07 %-1,500 %-801.83 %
2025e-350.07 %-1,450 %-1,336.39 %
2024e-350.07 %-1,150 %-1,336.39 %
2023-350.07 %-928 %267.43 %
2022-350.07 %-492.96 %-3,831.39 %
2021-350.07 %-2,880.32 %7,871.84 %
2020-350.07 %488.57 %-7,826.75 %
2019-350.07 %-1,985.67 %8,953.22 %
2018-350.07 %505.82 %992.84 %
2017-350.07 %-1,280.93 %7,288.76 %
2016-350.07 %-513.15 %-4,045.37 %
2015-350.07 %-1,488.78 %-35,848.84 %
2014-350.07 %-1,263.66 %-7,385.45 %
2013-350.07 %-1,186.87 %-3,178.18 %
2012-350.07 %-1,680.28 %-2,141.35 %
2011-350.07 %-1,496.95 %-3,379.29 %
2010-350.07 %-859.5 %-2,342.59 %
2009-29.98 %-143.7 %-9.27 %
2008-63.62 %-176.58 %-248.43 %
2007-4,966.67 %-6,833.33 %-6,877.78 %
2006-350.07 %0 %0 %

Karolinska Development Aktienanalyse

What does Karolinska Development do?

Karolinska Development AB is a Swedish investment company focused on promoting innovative biotech companies and start-ups. The company was founded in 2003 by the government of the Stockholm region and Karolinska Institutet University. The business model of Karolinska Development is designed to make profitable investments in promising biotech companies. It specifically supports companies in the areas of cancer treatment, immunotherapy, cardiovascular diseases, as well as neurology and psychiatry. The company provides capital and expertise to turn promising innovations into successful products. Karolinska Development operates different divisions to fulfill this purpose, including Karolinska Development AB (parent company), Karolinska Development Life Science Venture AB (a specialized investment company), and Karolinska Development Management AB (portfolio management team). Karolinska Development has built a strong portfolio of companies developing innovative products and therapies. One example is Modus Therapeutics AB, which has developed a new therapy for the treatment of sickle cell anemia. Another example is Aprea AB, a developer of gene therapies for combating cancer using tumor cells and genetic sequencing. The company's history is marked by many successful investments and acquisitions. One example is the acquisition of BioChromix AB in 2012, which developed a new technology for rapid and precise diagnosis of infectious diseases. Karolinska Development also actively participates in supporting new start-ups and company formations to promote promising innovations. Karolinska Development AB plays an important role in the biotech industry and significantly supports research in drug development. Through its unique position as an investor and partner for innovative companies, Karolinska Development is a driving force in the field of biotechnology. The company's business field is characterized by high risk and requires strategic thinking and skillful maneuvering in the market. However, Karolinska Development has managed to build a solid foundation and establish itself as an important player in the biotech industry through targeted investments, acquisitions, and partnerships. In summary, Karolinska Development plays a vital role in the biotech industry in Sweden and worldwide. The company has produced many innovative companies and products through targeted investments and acquisitions, contributing to changing lives and combating diseases. With its unique position as an investor and partner for biotech companies, Karolinska Development is well-equipped to continue promoting new innovations and advancing drug development in the future. Karolinska Development ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Net Income Details

Understanding Karolinska Development's Profit Margins

The profit margins of Karolinska Development represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Karolinska Development's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.

Year-to-Year Comparison

Evaluating Karolinska Development's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.

Impact on Investments

Karolinska Development's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.

Interpreting Profit Fluctuations

When Karolinska Development’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.

Frequently Asked Questions about Karolinska Development stock

How much profit has Karolinska Development made this year?

Karolinska Development has made -27.26 M SEK this year.

How has the profit developed compared to last year?

The profit has increased by -606.17% compared to last year fallen

What impact do the earnings have on the shareholders?

An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.

How does Karolinska Development publish its earnings?

Karolinska Development publishes its earnings in the form of quarterly or annual reports.

Which financial indicators are included in the quarterly or annual reports?

The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.

Why is it important for investors to know the earnings of Karolinska Development?

The profits of Karolinska Development are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.

How can one learn more about the earnings of Karolinska Development?

You can learn more about the earnings of Karolinska Development by reviewing the quarterly or annual reports or following the company presentations.

How much dividend does Karolinska Development pay?

Over the past 12 months, Karolinska Development paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Karolinska Development is expected to pay a dividend of 0 SEK.

What is the dividend yield of Karolinska Development?

The current dividend yield of Karolinska Development is .

When does Karolinska Development pay dividends?

Karolinska Development pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Karolinska Development?

Karolinska Development paid dividends every year for the past 0 years.

What is the dividend of Karolinska Development?

For the upcoming 12 months, dividends amounting to 0 SEK are expected. This corresponds to a dividend yield of 0 %.

In which sector is Karolinska Development located?

Karolinska Development is assigned to the 'Health' sector.

Wann musste ich die Aktien von Karolinska Development kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Karolinska Development from 9/6/2024 amounting to 0 SEK, you needed to have the stock in your portfolio before the ex-date on 9/6/2024.

When did Karolinska Development pay the last dividend?

The last dividend was paid out on 9/6/2024.

What was the dividend of Karolinska Development in the year 2023?

In the year 2023, Karolinska Development distributed 0 SEK as dividends.

In which currency does Karolinska Development pay out the dividend?

The dividends of Karolinska Development are distributed in SEK.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Karolinska Development

Our stock analysis for Karolinska Development Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Karolinska Development Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.